SCHEMBL4457262

SCHEMBL4457262

C[C@@H](Nc1ccc(-c2ccnc(Nc3ccc(N4CCN(C(=O)C(C)(C)C)CC4)cc3)n2)cc1)C(N)=O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JAK2 O60674 16/20 0.56
JAK3 P52333 10/20 0.56
JAK1 P23458 3/20 0.50
HDAC1 Q13547 2/20 0.50
HDAC6 Q9UBN7 2/20 0.50
TYK2 P29597 2/20 0.50
HDAC3 O15379 1/20 0.50
NCOR1 O75376 1/20 0.50
HDAC2 Q92769 1/20 0.50
HDAC8 Q9BY41 1/20 0.50
CDK2 P24941 4/20 0.49
AURKA O14965 1/20 0.49
CDK4 P11802 1/20 0.49
CDK7 P50613 1/20 0.49
CDK9 P50750 1/20 0.49
AURKB Q96GD4 1/20 0.49
CDK1 P06493 1/20 0.48
CCNB1 P14635 1/20 0.48
CCNE1 P24864 1/20 0.48
FLT3 P36888 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4383485 0.89 JAK2 (0.57) JAK2JAK3JAK1HDAC1HDAC6
SCHEMBL4387000 0.89 JAK2 (0.61) JAK2JAK3JAK1HDAC1HDAC6
SCHEMBL4378185 0.89 JAK2 (0.61) JAK2JAK3JAK1HDAC1HDAC6
SCHEMBL4378622 0.87 JAK2 (0.55) JAK2JAK3JAK1HDAC1HDAC6
SCHEMBL4380462 0.86 JAK2 (0.74) JAK2JAK3JAK1HDAC1HDAC6
SCHEMBL4387657 0.86 JAK2 (0.74) JAK2JAK3JAK1HDAC1HDAC6
SCHEMBL4380081 0.86 JAK2 (0.76) JAK2JAK3JAK1HDAC1HDAC6
SCHEMBL4380085 0.86 JAK2 (0.76) JAK2JAK3JAK1HDAC1HDAC6
SCHEMBL4384824 0.86 JAK2 (0.57) JAK2JAK3JAK1HDAC1HDAC6
SCHEMBL4374503 0.85 CDK2 (0.64) JAK2JAK3JAK1HDAC1HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009017838-A2 COMBINATIONS OF JAK-2 INHIBITORS AND OTHER AGENTS EXELIXIS, INC. (US) 2009-02-05 WO claimed
WO-2008124085-A2 METHODS OF USING COMBINATIONS OF MEK AND JAK-2 INHIBITORS EXELIXIS, INC. (US) 2008-10-16 WO claimed